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1. Introduction 
Glucocorticoids stimulate the synthesis of triacyl- 
glycerols and the secretion of very low density lipo- 
proteins by the liver [l-3]. The effect involves an 
increased activity of phosphatidate phosphohydrolase 
(EC 3 .I .3.4) and this enzyme appears to facilitate an 
increased rate of triacylglycerol synthesis in a variety 
of physiological conditions [3-61. Direct evidence for 
the involvement of cortisol in stimulating the phos- 
phohydrolase activity has been demonstrated with 
isolated perfused liver [4], but not with isolated hepa- 
tocytes. This work involves the latter system which 
can be more readily employed to investigate how a 
variety of hormones interact to control hepatic glyc- 
erolipid synthesis. The soluble phosphatidate phos- 
phohydrolase activity was stimulated by 10-9-10-6 M 
dexamethasone and by 1 Om6-1 O-’ M corticosterone, 
and increases of-2-fold were observed after 4-7 h 
incubation. The dexamethasone stimulation was abol- 
ished by cycloheximide, or actinomycin D. The 
increases were of a similar magnitude to those observed 
with tyrosine aminotransferase (EC 2.6.1 S), whose 
rate of synthesis is known to depend on the availabil- 
ity of glucocorticoids. 
The Radiochemical Centre, Amersham and general 
biochemicals and antibiotics were from Sigma Chemi- 
cal Co. (London) Ltd. 
2.2.Preparation and incubation of hepatocytes 
Hepatocyteswereprepared between 10:00-l 1:00 h 
from male Wistar rats fed ad libitum and kept in a 
roomlit from 08:00-20:00 h. They were anaethetized 
with an intraperitoneal injection of 60 mg sodium 
pentabarbitone/kg body wt and hepatocytes were 
prepared essentially as in [7]. An initial non-cyclic 
perfusion was performed with calcium-free Krebs- 
Henseleit buffer [8] containing 5 mM glucose, 20 mM 
Hepes (pH 7.4) and equilibrated with OZ/COZ (95:5, 
v/v). This was followed by a cyclic perfusion with the 
same buffer, except that 1.4 mM CaClz and 70 mg col- 
lagenase/ 100 ml was added. The liver was dispersed 
after 1 S-20 min by gentle shearing with scissors in 
the collagenase buffer and the cells were agitated in a 
Gallenkamp Orbital Shaker (70 rev./min) for 8 min. 
2. Materials and methods 
The mixture was filtered through a course plastic 
strainer and then through 142 pm and 62 pm stainless 
steel meshes. The resulting cells were washed 3 times 
by centrifuging at 50 X g for 2 min and resuspended 
in Eagle’s minimum essential medium containing 
Earle’s salts and 20 mM Hepes. Samples (500 pl) were 
used for each incubation. All of the steps above were 
performed with buffers equilibrated with Oz/COz 
(95:5,v/v) at 37°C. 
2.1 . Materials 
Collagenase (class I) was obtained from Millipore 
Corp., minimum essential medium with Earle’s salts 
and foetal calf serum from Gibco: Bio-Cult Ltd, 
Sagital (sodium pentabarbitone) from May and Baker 
Ltd, and actinomycin D (Lysovac) from Merck, Sharp 
and Dohme Intl. Radiochemicals were obtained from 
Incubations were performed at 37°C in siliconized 
25 ml conical flasks in which an atmosphere of 
OZ/COZ (95:5, v/v) was maintained by a rubber Suba- 
seal. The gas was replaced at 2 h intervals. Each flask 
contained 4 ml Eagle’s minimum essential medium 
including Earle’s salts, 20 mM Hepes buffer (pH 7.4), 
480 pg streptomycin, 800 U penicillin, 10% charcoal- 
Published by ElsevierlNorth-Holland Biomedical Press 
00145793/81/0000-0000/$02.75 0 1981 Federation of European Biochemical Societies 119 
Volume 133. number 1 E’EBS LETTERS October 1981 
treated [9] foetal calf serum and hepatocytes equiva- 
lent to -1 1 mg dry wt. Steroid hormones were dis- 
solved in methanol and the final concentrations were 
achieved by adding 5 ~1 of this solution/flask. Control 
incubations received 5 ~1 methanol and this addition 
did not alter the observed enzyme activities. 
2.3. Determination of enzyme activities and of A TP 
concentrations 
Each incubation was centrifuged at 50 X g for 
4 min. The resulting cell pellet was sonicated (22 kHz, 
5 s) in 1 ml 0.25 M sucrose (pH 7.4) at 4°C contain- 
ing 0.5 mM dithiothreitol; then frozen in liquid N, 
and stored at -20°C. Aliquots used for the determina- 
tion of tyrosine aminotransferase activity contained 
0.2 mM pyridoxal phosphate. 
The methods used to determine the activities of 
tyrosine aminotransferase [IO] and phosphatidate 
phosphohydrolase [ 1 l] were as described except that 
for phosphatidate phosphohydrolase determination, 
the specific radioactivity of [3H]phosphatidate was 
increased to 0.9 Ci/mol. The ATP concentrations of 
hepatocytes was measured as in [ 121, and this was used 
as an index of the metabolic viability of the cells [ 131. 
3. Results and discussion 
Dexamethasone (1 0W9- 1 0e6 M) and corticosterone 
(1 Od6-1 O-’ M) stimulated the activity of phosphati- 
0 /-----JO 
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loglo glucworticoid IM) 1 
Effect of glucocorticoid concentration on the activities 
of phosphatidate phosphohydrolase and tyrosine aminotrans- 
ferase in hepatocytes. The results from a representative xper- 
iment show the effects of varying the concentration of dexa- 
methasone on the activities of phosphatidate phosphohydrolase 
(0) and tyrosine aminotransferase (0) and the effects of corti- 
costerone on phosphatidate phosphohydrolase activity (A). 
date phosphohydrolase by -a-fold (fig.], table 1) and 
these stimulations were seen after -4 h incubation 
(fig.2). The greater effect of dexamethasone at lower 
concentrations agrees with other work concerning the 
potency of glucocorticoids [9,14]. The magnitude of 
the increases for the phosphohydrolase were of the 
Table 1 
Effect of glucocorticoids on the activities of phosphatidate phosphohydrolase and tyrosine aminotrans- 















Dexamethasone (10“ M) + 
actinomycin D (1 p&/ml) 
Actinomycin D (1 fig/ml) 
Dexamethasone (1 Ov7 M) + 
cycloheximide (5 fig/ml) 
Cycloheximide (5 &ml) 









386 r 119 (8) 
I vs 111a 
364 i: 101 (10) 
II YS III” 
779 i 171 (IO) 
III vs 1va 
302 + 102 (3) 
III YS 1va 
308 + 136 (3) 
156 + 9 (3) 
III YS v1a 
15s + 6 (3) 
628 _+ 213 (10) 
II vs VIIIC 
60 i 23 (5) 
39 f 10 (5) 
II vs 111a 
120 ? 32 (5) 






Results are means f SD (n); n.m., not measured. The significance of differences between groups was 
determined with an unpaired t-test and is indicated as follows: a P < 0.001; b P < 0.01; ‘P < 0.005 
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Fig.2. Time course of the stimulation of phosphatidate phos- 
phohydrolase activity by dexamethasone. The activities in 
control hepatocytes (0) and those treated with lo-’ M dexa- 
methasone (0) are shown from a representative experiment. 
same order as for tyrosine aminotransferase (fig.1, 
table l), whose synthesis is known to be induced by 
glucocorticoids [9 ,151. Here, there was no significant 
difference in the concentrations of dexamethasone 
needed to stimulate these two activities. The increases 
in phosphatidate phosphohydrolase compare reason- 
ably well with the 2.74-fold stimulation obtained in 
[4] by perfusing isolated livers with cortisol. In vivo, 
the phosphohydrolase activity has been observed to 
increase by 2-7-fold when the circulating levels of 
corticosterone increase from -0.1 PM to l-3 yM 
[16-191. 
In other experiments we replaced the foetal calf 
serum in the medium used for hepatocyte incubations 
by 20 mg fatty acid-poor bovine serum albumin/ml. 
This caused an -50% decrease in the phosphohydro- 
lase activity during 6.h incubation, and dexametha- 
sone failed to increase this low activity. In the presence 
of foetal calf serum the phosphohydrolase activity 
was maintained during the incubation, and glucocorti- 
coidinduced stimulations were reproducibly seen 
(table 1). These differences may be related to the 
metabolic viability of the cells, since the initial ATP 
level of -8 nmol/mg dry wt of cells fell by -70% 
during the 6 h incubation with albumin. By contrast, 
only -15% of the ATP was lost when foetal calf serum 
was used. 
The glucocorticoids probably increased the phos- 
phohydrolase activity by stimulating its synthesis, 
since both cycloheximide and actinomycin D block 
the increase (table 1). Actinomycin D also prevented 
the increases in activity that were observed in vitro 
after perfusing livers with cortisol [4], and those seen 
in vivo after subtotal hepatectomy [20]. 
This work characterises the conditions under which 
dexamethasone and corticosterone can increase the 
activity of phosphatidate phosphohydrolase in isolated 
hepatocytes. This system is suitable for determining 
how other hormones interact with glucocorticoids to 
control hepatic glycerolipid synthesis. The results also 
demonstrate that the glucocorticoid-induced increases 
in phosphohydrolase activity are similar to those for 
tyrosine aminotransferase. These findings indicate 
that the increased potential to synthesise triacylglyc- 
erols is probably coordinated with an increased capac- 
ity for gluconeogenesis. This may be particularly 
important in stress conditions in which the liver con- 
verts excess fatty acids to ketones and triacylglycerols 
which can then be exported to skeletal and cardiac 
muscles as a source of energy [6]. In a similar manner, 
the brain is being supplied with glucose and ketones 
by the liver. 
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